Search research articles
Contact Us
Filters
Showing results (131-140 of 158) with videos related to
Page
of 16
Sort By:
Nature Communications
|
October 20, 2019
Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa
Jon Cantero-Pérez, Judith Grau-Expósito, Carla Serra-Peinado, et al.
Arthritis Care & Research
|
October 13, 2017
Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial
Jeffrey A Sparks, Maura D Iversen, Zhi Yu, et al.
Vaccines
|
June 24, 2022
Neurocognitive Profile of the Post-COVID Condition in Adults in Catalonia-A Mixed Method Prospective Cohort and Nested Case-Control Study: Study Protocol
Rosalia Dacosta-Aguayo, Noemí Lamonja-Vicente, Carla Chacón, et al.
Journal of AOAC International
|
July 9, 2005
Determination of ochratoxin A in green coffee by immunoaffinity column cleanup and liquid chomatography: collaborative study
Eugênia Azevedo Vargas, Eliene Alves dos Santos, Alain Pittet, et al.
The Journal of Experimental Medicine
|
April 7, 2004
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection
Rika Draenert, Sylvie Le Gall, Katja J Pfafferott, et al.
JCI Insight
|
January 5, 2023
Slow progression of pediatric HIV associates with early CD8+ T cell PD-1 expression and a stem-like phenotype
Vinicius Vieira, Nicholas Lim, Alveera Singh, et al.
AJNR. American Journal of Neuroradiology
|
April 4, 2024
Reduced Cortical Thickness Correlates of Cognitive Dysfunction in Post-COVID-19 Condition: Insights from a Long-Term Follow-up
Rosalia Dacosta-Aguayo, Josep Puig, Noemi Lamonja-Vicente, et al.
JAMA Oncology
|
April 10, 2020
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study
Maria Gonzalez-Cao, Teresa Morán, Judith Dalmau, et al.
Plos One
|
July 22, 2025
Participant engagement in a national longitudinal study of COVID-19: Insights from the INSPIRE study
Kris Pui Kwan Ma, Tracy Stober, Michael Gottlieb, et al.
Journal of Virology
|
December 8, 2017
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection
María Pernas, Laura Tarancón-Diez, Esther Rodríguez-Gallego, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 158) with videos related to
Sort By:
Page
of 16
Nature Communications
|
October 20, 2019
Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa
Jon Cantero-Pérez, Judith Grau-Expósito, Carla Serra-Peinado, et al.
Arthritis Care & Research
|
October 13, 2017
Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial
Jeffrey A Sparks, Maura D Iversen, Zhi Yu, et al.
Vaccines
|
June 24, 2022
Neurocognitive Profile of the Post-COVID Condition in Adults in Catalonia-A Mixed Method Prospective Cohort and Nested Case-Control Study: Study Protocol
Rosalia Dacosta-Aguayo, Noemí Lamonja-Vicente, Carla Chacón, et al.
Journal of AOAC International
|
July 9, 2005
Determination of ochratoxin A in green coffee by immunoaffinity column cleanup and liquid chomatography: collaborative study
Eugênia Azevedo Vargas, Eliene Alves dos Santos, Alain Pittet, et al.
The Journal of Experimental Medicine
|
April 7, 2004
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection
Rika Draenert, Sylvie Le Gall, Katja J Pfafferott, et al.
JCI Insight
|
January 5, 2023
Slow progression of pediatric HIV associates with early CD8+ T cell PD-1 expression and a stem-like phenotype
Vinicius Vieira, Nicholas Lim, Alveera Singh, et al.
AJNR. American Journal of Neuroradiology
|
April 4, 2024
Reduced Cortical Thickness Correlates of Cognitive Dysfunction in Post-COVID-19 Condition: Insights from a Long-Term Follow-up
Rosalia Dacosta-Aguayo, Josep Puig, Noemi Lamonja-Vicente, et al.
JAMA Oncology
|
April 10, 2020
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study
Maria Gonzalez-Cao, Teresa Morán, Judith Dalmau, et al.
Plos One
|
July 22, 2025
Participant engagement in a national longitudinal study of COVID-19: Insights from the INSPIRE study
Kris Pui Kwan Ma, Tracy Stober, Michael Gottlieb, et al.
Journal of Virology
|
December 8, 2017
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection
María Pernas, Laura Tarancón-Diez, Esther Rodríguez-Gallego, et al.
Page
of 16